sq-11725 has been researched along with cl 316243 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atef, N; Doublé, A; Hélary, C; Ktorza, A; Lafontan, M; Pénicaud, L | 1 |
Erfanian, M; Gauthier, C; Heymann, MF; Langin, D; Laurent, K; Tavernier, G; Toumaniantz, G | 1 |
Bundgaard, H; Chia, KK; Figtree, GA; Garcia, A; Hamilton, EJ; Huang, Y; Hunyor, SN; Liu, CC; Rasmussen, HH | 1 |
3 other study(ies) available for sq-11725 and cl 316243
Article | Year |
---|---|
A specific beta 3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Female; Insulin; Insulin Secretion; Islets of Langerhans; Nadolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Regional Blood Flow | 1996 |
beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blotting, Western; Bupranolol; Cyclic GMP; Depression, Chemical; Dioxoles; Electrocardiography; Humans; Mice; Mice, Transgenic; Models, Animal; Myocardial Contraction; Myocardium; Nadolol; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes | 2003 |
β(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dioxoles; Disease Models, Animal; Ethanolamines; Glutathione; Heart Failure; Mice; Mice, Knockout; Myocardial Contraction; Myocytes, Cardiac; Nadolol; Oxidative Stress; Patch-Clamp Techniques; Rabbits; Receptors, Adrenergic, beta-3; Sheep; Sodium; Sodium-Potassium-Exchanging ATPase | 2010 |